British Columbia-based Tilray reached an agreement with a subsidiary of Swiss pharmaceutical giant Novartis AG in which the Canadian firm\u2019s medical marijuana will eventually be produced and distributed in countries where MMJ is legal. Tilray\u2019s deal with Quebec-based Sandoz AG\u00a0is an extension of a\u00a0letter of intent\u00a0the companies signed in March to produce\u00a0co-branded, nonsmokable and noncombustible [\u2026]<\/p>\n
Canadian medical cannabis firm Tilray eyes global reach in deal with Novartis subsidiary<\/a> is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n
British Columbia-based Tilray reached an agreement with a subsidiary of Swiss pharmaceutical giant Novartis AG in which the Canadian firm\u2019s medical marijuana will eventually be produced and distributed in countries where MMJ is legal. Tilray\u2019s deal with Quebec-based Sandoz AG\u00a0is an extension of a\u00a0letter of intent\u00a0the companies signed in MarchContinue Reading<\/a><\/span><\/p>\n","protected":false},"author":39,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4,682,2786,3704,6810,1088],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/31492"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=31492"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/31492\/revisions"}],"predecessor-version":[{"id":31493,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/31492\/revisions\/31493"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=31492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=31492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=31492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n
\nRead More: Canadian medical cannabis firm Tilray eyes global reach in deal with Novartis subsidiary<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"